8-K - Immunome, Inc. | StockGist

Current Report Details

Event Type

Other Event

Exhibits Only

Disclosure

Voluntary

Variant

8-K

Items Reported

8.01

Other Events. Follow-On Public Offering On December 16, 2025, Immunome, Inc. (the “Company”) entered into an underwriting agreement (the “Underwriting Agreement

Other Event

$21.50$400.0M

9.01

Financial Statements and Exhibits. (d) Exhibits. Exhibit No. Description 1.1 Underwriting Agreement by and among the Company, Leerink Partners LLC, J.P. Morgan

Exhibits Only

Source Document

Exhibits (5)

1.1

EX-1.1

5.1

EX-5.1

8-K

99.1

EX-99.1

99.2

EX-99.2